English | Español

Shire
Nicholas Gueguen | Jun 30, 2017

Shire study sees reduction in hereditary angioedema episodes using lanadelumab
Ruth de Jauregui | May 3, 2017

Study indicates one bleeding incident every 3-15 seconds among hemophiliacs
Robert Hadley | Apr 28, 2017

Shire’s hashtag campaign focusing on primary immunodeficiency
Keri Carbaugh | Feb 6, 2017

Shire takes lead on rare conditions, CEO says
Keri Carbaugh | Jan 18, 2017

Shire again offers scholarship for students with ADHD
Amanda Rupp | Jun 11, 2016

Shire shareholders approve Baxalta merger
Amanda Rupp | Jun 7, 2016

CHMP gives positive opinion of short bowl syndrome pediatric medicine
Amanda Rupp | Apr 17, 2016

Shire sends application to FDA for chewable Vyvanse tablets

Trending
+ Technology/Innovation
Patient Daily News Service | Oct 9, 2025

Babylon Health collapse raises questions about AI claims across industries
Patient Daily | Oct 9, 2025

Medfluence Advisors Marketing Expert: 'The conversations leading into AAO-HNSF are shaping how ENT practices approach growth and engagement'
+ Pharmaceuticals
Patient Daily | Oct 8, 2025

American Lung Association launches campaign urging vaccinations against seasonal flu and respiratory illnesses
Patient Daily | Oct 6, 2025

Drug Channels Institute president: ‘A growing share of 340B dollars are captured by for-profit pharmacies and PBMs’